FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to compound of structural formula
,
which can be applied for treatment, prevention or carrying out treatment of neurological disorder. In formula (Iva) m is equal 0; n is equal 1; R1 and R2 are, each independently, hydrogen, C1-C4alkyl or C3-C6cycloalkyl; R3 and R4 are, each independently, hydrogen or C1-C4alkyl; R5 is hydrogen and R6 and R7 are, each independently hydrogen, halogen, C1-C4alkyl, C6-C10aryl, 5-10-membered heteroaryl, which contains one O atom, one S atom and/or 1-4 N atom(s), 3-8-membered heterocyclyl, containing 1-2 heteroatoms, selected from O, S and N, C1-C4alcoxyl or aminoC1-C4alkyl.
EFFECT: invention relates to pharmaceutical industry, which contains claimed compound, and to method of treatment, prevention or carrying out of treatment of neurological disorder such as psychosis or schizophrenia.
54 cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| POLYCYCLIC COMPOUNDS AND METHODS FOR THEIR USE | 2010 |
|
RU2641648C1 |
| POLYCYCLIC COMPOUNDS AND METHODS OF USE THEREOF | 2010 |
|
RU2707067C2 |
| GLYCOLATOXIDASE INHIBITORS FOR THE TREATMENT OF DISEASES | 2018 |
|
RU2805308C2 |
| HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS | 2010 |
|
RU2615130C2 |
| MACROHETEROCYCLIC COMPOUNDS | 2001 |
|
RU2275373C2 |
| INDOLE DERIVATIVES AS HISTAMINE H-RECEPTOR INHIBITORS FOR TREATING COGNITIVE DISORDERS AND SLEEP DISTURBANCES, OBESITY AND OTHER DISORDERS OF CENTRAL NERVOUS SYSTEM | 2006 |
|
RU2423360C2 |
| 2,5-DISUBSTITUTED ARYLSULPHONAMIDE CCR3 ANTAGONISTS | 2010 |
|
RU2532515C2 |
| DIHYDROPYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE | 2009 |
|
RU2514937C2 |
| METHODS FOR TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES WITH USE OF 2,4-PYRIMIDINEDIAMINE | 2013 |
|
RU2659777C2 |
| PHOSPHOINDOLES AS HIV INHIBITORS | 2005 |
|
RU2393163C2 |
